Bisthianostat - CAS 1408234-79-6

Bisthianostat, also known as CF367 or CF367; -C, is a novel Orally Efficacious Pan-HDAC Inhibitor. Bisthianostat selectively binds to and inhibits HDACs, which inhibits deacetylation of histone proteins and leads to the accumulation of highly acetylated histones. This may result in an induction of chromatin remodeling, the inhibition of tumor oncogene transcription, and the selective transcription of tumor suppressor genes. This prevents cell division, induces cell cycle arrest and apoptosis. This may inhibit the proliferation of susceptible tumor cells. HDACs, upregulated in many tumor cell types, are a family of enzymes that deacetylate histone proteins.

Others

Others

1408149

C15H18N4O3S2

366.46

C(NCCCCC(NO)=O)(=O)C1=C(SC(=N1)C2=NC=CS2)C3CC3

-20°C

Ice Packs

Small Compound